Taylor Frigon Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.37M | Buy |
4,504
+910
| +25% | +$510K | 1.11% | 34 |
|
|
2026
Q1 | $2.02M | Sell |
3,594
-24
| -0.7% | -$15.4K | 1.15% | 39 |
|
|
2025
Q4 | $2.45M | Sell |
3,618
-37
| -1% | -$25.2K | 1.24% | 24 |
|
|
2025
Q3 | $2.34M | Sell |
3,655
-1,037
| -22% | -$629K | 1.16% | 39 |
|
|
2025
Q2 | $2.52M | Sell |
4,692
-336
| -7% | -$161K | 1.34% | 25 |
|
|
2025
Q1 | $2.11M | Sell |
5,028
-119
| -2% | -$51.7K | 1.25% | 26 |
|
|
2024
Q4 | $2.13M | Sell |
5,147
-536
| -9% | -$235K | 1.08% | 39 |
|
|
2024
Q3 | $2.88M | Sell |
5,683
-628
| -10% | -$305K | 1.44% | 20 |
|
|
2024
Q2 | $3.07M | Sell |
6,311
-41
| -0.6% | -$20.6K | 1.46% | 23 |
|
|
2024
Q1 | $3.43M | Sell |
6,352
-81
| -1% | -$44.3K | 1.63% | 22 |
|
|
2023
Q4 | $3.57M | Sell |
6,433
-167
| -3% | -$78.4K | 1.79% | 20 |
|
|
2023
Q3 | $2.89M | Sell |
6,600
-13
| -0.2% | -$6.48K | 1.6% | 19 |
|
|
2023
Q2 | $3.32M | Sell |
6,613
-619
| -9% | -$297K | 1.62% | 20 |
|
|
2023
Q1 | $3.62M | Sell |
7,232
-189
| -3% | -$90.4K | 1.98% | 14 |
|
|
2022
Q4 | $3.03M | Sell |
7,421
-436
| -6% | -$169K | 1.72% | 17 |
|
|
2022
Q3 | $2.56M | Buy |
7,857
+55
| +0.7% | +$20.2K | 1.33% | 26 |
|
|
2022
Q2 | $2.74M | Sell |
7,802
-399
| -5% | -$163K | 1.42% | 25 |
|
|
2022
Q1 | $4.49M | Sell |
8,201
-2
| -0% | -$1.05K | 1.67% | 22 |
|
|
2021
Q4 | $5.4M | Sell |
8,203
-30
| -0.4% | -$18.8K | 1.69% | 19 |
|
|
2021
Q3 | $5.12M | Sell |
8,233
-141
| -2% | -$94.7K | 1.65% | 25 |
|
|
2021
Q2 | $5.29M | Sell |
8,374
-502
| -6% | -$277K | 1.65% | 27 |
|
|
2021
Q1 | $4.34M | Sell |
8,876
-84
| -0.9% | -$42.1K | 1.34% | 37 |
|
|
2020
Q4 | $4.48M | Buy |
8,960
+129
| +1% | +$57.7K | 1.47% | 35 |
|
|
2020
Q3 | $3.47M | Buy |
8,831
+78
| +0.9% | +$28.8K | 1.53% | 26 |
|
|
2020
Q2 | $2.89M | Sell |
8,753
-7
| -0.1% | -$2.03K | 1.44% | 27 |
|
|
2020
Q1 | $2.12M | Buy |
8,760
+1,505
| +21% | +$393K | 1.66% | 18 |
|
|
2019
Q4 | $1.89M | Sell |
7,255
-850
| -10% | -$224K | 1.31% | 32 |
|
|
2019
Q3 | $2.2M | Sell |
8,105
-424
| -5% | -$118K | 1.59% | 14 |
|
|
2019
Q2 | $2.35M | Buy |
8,529
+621
| +8% | +$153K | 1.63% | 17 |
|
|
2019
Q1 | $1.77M | Sell |
7,908
-126
| -2% | -$26K | 1.38% | 28 |
|
|
2018
Q4 | $1.49M | Sell |
8,034
-2
| -0% | -$410 | 1.31% | 34 |
|
|
2018
Q3 | $2.01M | Sell |
8,036
-1,206
| -13% | -$293K | 1.52% | 22 |
|
|
2018
Q2 | $2.01M | Sell |
9,242
-473
| -5% | -$97.5K | 1.46% | 24 |
|
|
2018
Q1 | $1.86M | Buy |
9,715
+622
| +7% | +$115K | 1.45% | 29 |
|
|
2017
Q4 | $1.42M | Buy |
+9,093
| New | +$1.43M | 1.14% | 36 |
|
|
2016
Q2 | $1.75M | Sell |
18,818
-499
| -3% | -$42.9K | 1.82% | 11 |
|
|
2016
Q1 | $1.51M | Buy |
19,317
+685
| +4% | +$49.3K | 1.6% | 21 |
|
|
2015
Q4 | $1.34M | Sell |
18,632
-391
| -2% | -$27.9K | 1.51% | 28 |
|
|
2015
Q3 | $1.4M | Buy |
19,023
+355
| +2% | +$25.4K | 1.56% | 28 |
|
|
2015
Q2 | $1.19M | Sell |
18,668
-658
| -3% | -$45.6K | 1.23% | 40 |
|
|
2015
Q1 | $1.48M | Sell |
19,326
-5,672
| -23% | -$441K | 1.37% | 36 |
|
|
2014
Q4 | $1.85M | Buy |
+24,998
| New | +$1.75M | 1.74% | 7 |
|
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
CC
Taylor Frigon Capital Management's IDXX Position: Q2 2026 in Review
Taylor Frigon Capital Management increased its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, buying an estimated $510K and bringing the position to 4,504 shares worth $2.37M. The position accounts for 1.11% of the portfolio, ranked #34.
Taylor Frigon Capital Management first reported a position in IDXX in Q4 2014 and has held it in 42 quarters since. The position peaked at $5.4M in Q4 2021. 408 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Taylor Frigon Capital Management held 4,504 shares of Idexx Laboratories worth $2.37M as of Q2 2026.
- Taylor Frigon Capital Management bought 910 Idexx Laboratories shares in Q2 2026, an estimated $510K.
- Idexx Laboratories made up 1.11% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #34 holding.
- Taylor Frigon Capital Management first reported a position in Idexx Laboratories in Q4 2014 and has held it in 42 quarters since.
- Taylor Frigon Capital Management's Idexx Laboratories position peaked at $5.4M in Q4 2021.
- 408 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.